Literature DB >> 9282747

Type III secretion genes identify a putative virulence locus of Chlamydia.

R C Hsia1, Y Pannekoek, E Ingerowski, P M Bavoil.   

Abstract

Four genes of Chlamydia psittaci strain guinea pig inclusion conjunctivitis (GPIC), whose predicted products are highly homologous to structural and regulatory components of a contact-dependent or type III secretion apparatus, were isolated. Related to genes present in several animal and plant bacterial pathogens, these genes may represent a section of a previously undetected chromosomal virulence locus analogous to several recently described virulence-associated type III secretion loci. The existence of contact-dependent secretion in Chlamydia strongly suggests that these bacteria use pathogenic mechanisms that are similar to those of other intracellular bacterial pathogens. Unlike other intracellular bacteria, however, chlamydiae are metabolically inactive extracellularly and only become capable of global protein synthesis several hours after infection. This implies that chlamydial contact-dependent secretion is only active from within, uniquely after the bacteria have been internalized by eukaryotic cells. The possible role(s) of this pathway in chlamydial pathogenesis are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9282747     DOI: 10.1046/j.1365-2958.1997.4701834.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  58 in total

1.  Cloning, characterization, and expression of a novel gene encoding a reversible 4-hydroxybenzoate decarboxylase from Clostridium hydroxybenzoicum.

Authors:  J Huang; Z He; J Wiegel
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

2.  Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis.

Authors:  K Rajalingam; H Al-Younes; A Müller; T F Meyer; A J Szczepek; T Rudel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Genomic approach for analysis of surface proteins in Chlamydia pneumoniae.

Authors:  Silvia Montigiani; Fabiana Falugi; Maria Scarselli; Oretta Finco; Roberto Petracca; Giuliano Galli; Massimo Mariani; Roberto Manetti; Mauro Agnusdei; Roberto Cevenini; Manuela Donati; Renzo Nogarotto; Nathalie Norais; Ignazio Garaguso; Sandra Nuti; Giulietta Saletti; Domenico Rosa; Giulio Ratti; Guido Grandi
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 4.  Genome sequencing and our understanding of chlamydiae.

Authors:  D D Rockey; J Lenart; R S Stephens
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Temporal expression of type III secretion genes of Chlamydia pneumoniae.

Authors:  Anatoly Slepenkin; Vladimir Motin; Luis M de la Maza; Ellena M Peterson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae.

Authors:  R Lugert; M Kuhns; T Polch; U Gross
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

7.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.

Authors:  Sandra Muschiol; Gaelle Boncompain; François Vromman; Pierre Dehoux; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 8.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Electron tomography and cryo-SEM characterization reveals novel ultrastructural features of host-parasite interaction during Chlamydia abortus infection.

Authors:  M Wilkat; E Herdoiza; V Forsbach-Birk; P Walther; A Essig
Journal:  Histochem Cell Biol       Date:  2014-02-13       Impact factor: 4.304

10.  Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.

Authors:  Anatoly Slepenkin; Per-Anders Enquist; Ulrik Hägglund; Luis M de la Maza; Mikael Elofsson; Ellena M Peterson
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.